Evaluation of the safety and efficiency of intracameral moxifloxacin by using bag and chamber flushing method in cataract surgery

Evaluation of the safety and efficiency of intracameral moxifloxacin by using bag and chamber flushing method in cataract surgery - Intracameral moxifloxacin test

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009454

Enrollment

Registered

2012-12-01

Start date

2012-01-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract

Interventions

Left eye: intracameral moxifloxacin, Reight eye: only BSS(control group)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: cataract surgery of both eye

Exclusion criteria

Exclusion criteria: macular disease(CMT over300), postsurgery of ocular disease and post refractive surgery

Design outcomes

Primary

Measure	Time frame
CD and CCT by specular microscopy (pre,post1w,2w,1m,3m), CMT by OCT(pre,post1w,2w,1m,3m),	—

Secondary

Measure	Time frame
CDVA,grade of flare, endophthalmitis(Y/N)	—

Countries

Japan

Contacts

Public ContactChikako Suto

Saiseikai Kurihashi Hospital Ophthalmology

chikakos@pastel.ocn.ne.jp

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026